One of the first reviews of the human papillomavirus (HPV) vaccine has shown that it has reduced the risk of cervical cancer death before age 30 to effectively zero in the United Kingdom.
The study, published by The Lancet medical journal on Wednesday this week, has shown remarkable results, experts say, raising hopes in other countries where the vaccine is also being rolled out.
Cervical ...

2 hours ago
6








English (US) ·